|
1
|
Gutiérrez G, Gresh L, Pérez MÁ, Elizondo
D, Avilés W, Kuan G, Balmaseda A and Harris E: Evaluation of the
diagnostic utility of the traditional and revised WHO dengue case
definitions. PLoS Negl Trop Dis. 7:e23852013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Horstick O, Jaenisch T, Martinez E,
Kroeger A, See LL, Farrar J and Ranzinger SR: Comparing the
usefulness of the 1997 and 2009 WHO dengue case classification: A
systematic literature review. Am J Trop Med Hyg. 91:621–634. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Narvaez F, Gutierrez G, Pérez MA, Elizondo
D, Nuñez A, Balmaseda A and Harris E: Evaluation of the traditional
and revised WHO classifications of Dengue disease severity. PLoS
Negl Trop Dis. 5:e13972011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Henchal EA and Putnak JR: The dengue
viruses. Clin Microbiol Rev. 3:376–396. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sabin AB: Research on dengue during World
War II. Am J Trop Med Hyg. 1:30–50. 1952.PubMed/NCBI
|
|
6
|
Rothman AL: Dengue: Defining protective
versus pathologic immunity. J Clin Invest. 113:946–951. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Halstead SB: Neutralization and
antibody-dependent enhancement of dengue viruses. Adv Virus Res.
60:421–467. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kuhn RJ, Zhang W, Rossmann MG, Pletnev SV,
Corver J, Lenches E, Jones CT, Mukhopadhyay S, Chipman PR, Strauss
EG, et al: Structure of dengue virus: Implications for flavivirus
organization, maturation, and fusion. Cell. 108:717–725. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rey FA, Heinz FX, Mandl C, Kunz C and
Harrison SC: The envelope glycoprotein from tick-borne encephalitis
virus at 2 A resolution. Nature. 375:291–298. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Crill WD, Hughes HR, Delorey MJ and Chang
GJ: Humoral immune responses of dengue fever patients using
epitope-specific serotype-2 virus-like particle antigens. PLoS One.
4:e49912009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wahala WM, Kraus AA, Haymore LB,
Accavitti-Loper MA and de Silva AM: Dengue virus neutralization by
human immune sera: Role of envelope protein domain III-reactive
antibody. Virology. 392:103–113. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Crill WD and Roehrig JT: Monoclonal
antibodies that bind to domain III of dengue virus E glycoprotein
are the most efficient blockers of virus adsorption to Vero cells.
J Virol. 75:7769–7773. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chua AJ, Vituret C, Tan ML, Gonzalez G,
Boulanger P, Ng ML and Hong SS: A novel platform for virus-like
particle-display of flaviviral envelope domain III: Induction of
Dengue and West Nile virus neutralizing antibodies. Virol J.
10:1292013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen HW, Liu SJ, Li YS, Liu HH, Tsai JP,
Chiang CY, Chen MY, Hwang CS, Huang CC, Hu HM, et al: A consensus
envelope protein domain III can induce neutralizing antibody
responses against serotype 2 of dengue virus in non-human primates.
Arch Virol. 158:1523–1531. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lok SM, Kostyuchenko V, Nybakken GE,
Holdaway HA, Battisti AJ, Sukupolvi-Petty S, Sedlak D, Fremont DH,
Chipman PR, Roehrig JT, et al: Binding of a neutralizing antibody
to dengue virus alters the arrangement of surface glycoproteins.
Nat Struct Mol Biol. 15:312–317. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Matsui K, Gromowski GD, Li L and Barrett
AD: Characterization of a dengue type-specific epitope on dengue 3
virus envelope protein domain III. J Gen Virol. 91:2249–2253. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rajamanonmani R, Nkenfou C, Clancy P, Yau
YH, Shochat SG, Sukupolvi-Petty S, Schul W, Diamond MS, Vasudevan
SG and Lescar J: On a mouse monoclonal antibody that neutralizes
all four dengue virus serotypes. J Gen Virol. 90:799–809. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wahala WM, Donaldson EF, de Alwis R,
Accavitti-Loper MA, Baric RS and de Silva AM: Natural strain
variation and antibody neutralization of dengue serotype 3 viruses.
PLoS Pathog. 6:e10008212010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yamanaka A, Kosugi S and Konishi E:
Infection-enhancing and -neutralizing activities of mouse
monoclonal antibodies against dengue type 2 and 4 viruses are
controlled by complement levels. J Virol. 82:927–937. 2008.
View Article : Google Scholar :
|
|
20
|
de Alwis R, Smith SA, Olivarez NP, Messer
WB, Huynh JP, Wahala WM, White LJ, Diamond MS, Baric RS, Crowe JE
Jr and de Silva AM: Identification of human neutralizing antibodies
that bind to complex epitopes on dengue virions. Proc Natl Acad Sci
USA. 109:7439–7444. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Midgley CM, Bajwa-Joseph M, Vasanawathana
S, Limpitikul W, Wills B, Flanagan A, Waiyaiya E, Tran HB, Cowper
AE, Chotiyarnwong P, et al: An in-depth analysis of original
antigenic sin in dengue virus infection. J Virol. 85:410–421. 2011.
View Article : Google Scholar :
|
|
22
|
Williams KL, Wahala WM, Orozco S, de Silva
AM and Harris E: Antibodies targeting dengue virus envelope domain
III are not required for serotype-specific protection or prevention
of enhancement in vivo. Virology. 429:12–20. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ding X, Hu D, Chen Y, Di B, Jin J, Pan Y,
Qiu L, Wang Y, Wen K, Wang M and Che X: Full serotype- and
group-specific NS1 capture enzyme-linked immunosorbent assay for
rapid differential diagnosis of dengue virus infection. Clin
Vaccine Immunol. 18:430–434. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cai JP, Qian F, Wang JY, Zhao Y, Xu XJ,
Jin WR and Che XY: Characterization and secreted expression of
dengue virus type I-IV envelope glycoprotein domain III in Pichia
pastoris. Zhonghua Yu Fang Yi Xue Za Zhi. 44:721–725. 2010.In
Chinese. PubMed/NCBI
|
|
25
|
Knapp W, Holubar K and Wick G:
Immunofluorescence and related staining techniques. Journal.
2151978.
|
|
26
|
Bai Z, Liu L, Tu Z, Yao L, Liu J, Xu B,
Tang B, Liu J, Wan Y, Fang M, et al: Real-time PCR for detecting
circulating dengue virus in the Guangdong Province of China in
2006. J Med Microbiol. 57:1547–1552. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bai Z, Liu L, Tu Z, Yao L, Liu J, Xu B,
Tang B, Liu J, Wan Y, Fang M, et al: Real-time PCR for detecting
circulating dengue virus in the Guangdong Province of China in
2006. J Med Microbiol. 57:1547–1552. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu L, Wen K, Li J, Hu D, Huang Y, Qiu L,
Cai J and Che X: Comparison of plaque- and enzyme-linked
immunospot-based assays to measure the neutralizing activities of
monoclonal antibodies specific to domain III of dengue virus
envelope protein. Clin Vaccine Immunol. 19:73–78. 2012. View Article : Google Scholar :
|
|
29
|
Li XQ, Chen J, Huang YF, Ding XX, Liu LD,
Qiu LW, Pan YX, Deng YQ, Hu DM, Di B, et al: Evaluation and
analysis of dengue virus enhancing and neutralizing activities
using simple high-throughput assays. Appl Microbiol Biotechnol.
97:6503–6511. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wahala WM and Silva AM: The human antibody
response to dengue virus infection. Viruses. 3:2374–2395. 2011.
View Article : Google Scholar
|
|
31
|
Valdés K, Alvarez M, Pupo M, Vázquez S,
Rodriguez R and Guzmán MG: Human dengue antibodies against
structural and nonstructural proteins. Clin Diagn Lab Immunol.
7:856–857. 2000.PubMed/NCBI
|
|
32
|
Lai CY, Tsai WY, Lin SR, Kao CL, Hu HP,
King CC, Wu HC, Chang GJ and Wang WK: Antibodies to envelope
glycoprotein of dengue virus during the natural course of infection
are predominantly cross-reactive and recognize epitopes containing
highly conserved residues at the fusion loop of domain II. J Virol.
82:6631–6643. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Abubakar S, Azila A, Suzana M and Chang
LY: Antigenic cell associated dengue 2 virus proteins detected in
vitro using dengue fever patients sera. Malays J Pathol. 24:29–36.
2002.
|
|
34
|
Cregg JM, Vedvick TS and Raschke WC:
Recent advances in the expression of foreign genes in Pichia
pastoris. Biotechnology (NY). 11:905–910. 1993. View Article : Google Scholar
|
|
35
|
Higgins DR: Overview of protein expression
in Pichia pastoris. Curr Protoc Protein Sci. Chapter 5: Unit5.
72001.
|
|
36
|
Ramón A and Marín M: Advances in the
production of membrane proteins in Pichia pastoris. Biotechnol J.
6:700–706. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Saokaew N, Poungpair O, Panya A, Tarasuk
M, Sawasdee N, Limjindaporn T, Chaicumpa W and Yenchitsomanus P:
Human monoclonal single-chain antibodies specific to dengue virus
envelope protein. Lett Appl Microbiol. 58:270–277. 2014. View Article : Google Scholar
|
|
38
|
Zhao H, Jiang T, Zhou XZ, Deng YQ, Li XF,
Chen SP, Zhu SY, Zhou X, Qin ED and Qin CF: Induction of
neutralizing anti-bodies against four serotypes of dengue viruses
by MixBiEDIII, a tetravalent dengue vaccine. PLoS One.
9:e865732014. View Article : Google Scholar
|
|
39
|
Galula JU, Shen WF, Chuang ST, Chang GJ
and Chao DY: Virus-like particle secretion and genotype-dependent
immunogenicity of dengue virus serotype 2 DNA vaccine. J Virol.
88:10813–10830. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chiang CY, Pan CH, Hsieh CH, Tsai JP, Chen
MY, Liu HH, Liu SJ, Chong P, Leng CH and Chen HW: Lipidated
dengue-2 envelope protein domain III independently stimulates
long-lasting neutralizing antibodies and reduces the risk of
antibody-dependent enhancement. PLoS Negl Trop Dis. 7:e24322013.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Coconi-Linares N, Ortega-Dávila E,
López-González M, García-Machorro J, García-Cordero J, Steinman RM,
Cedillo-Barrón L and Gómez-Lim MA: Targeting of envelope domain III
protein of DENV type 2 to DEC-205 receptor elicits neutralizing
antibodies in mice. Vaccine. 31:2366–2371. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sinha G: Sanofi's dengue vaccine first to
complete phase 3. Nat Biotechnol. 32:605–606. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wu W, Bai Z, Zhou H, Tu Z, Fang M, Tang B,
Liu J, Liu L, Liu J and Chen W: Molecular epidemiology of dengue
viruses in southern China from 1978 to 2006. Virol J. 8:3222011.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Jiang L, Wu X, Wu Y, Bai Z, Jing Q, Luo L,
Dong Z, Yang Z, Xu Y, Cao Y, et al: Molecular epidemiological and
virological study of dengue virus infections in Guangzhou, China,
during 2001–2010. Virol J. 10:42013. View Article : Google Scholar
|
|
45
|
Guo RN, Lin JY, Li LH, Ke CW, He JF, Zhong
HJ, Zhou HQ, Peng ZQ, Yang F and Liang WJ: The prevalence and
endemic nature of dengue infections in Guangdong, South China: An
epidemiological, serological, and etiological study from 2005–2011.
PLoS One. 9:e855962014. View Article : Google Scholar
|
|
46
|
Guo R, Peng Z, Song T, He J, Zhong H, Li L
and Liang W: Current infection status and epidemic risk analysis of
dengue fever and Chikungunya in Guangdong province, from 1990 to
2012. Zhonghua Liu Xing Bing Xue Za Zhi. 35:167–169. 2014.In
Chinese. PubMed/NCBI
|
